Clonidine treatment for agitation in children after sevoflurane anesthesia

Anesth Analg. 2005 Dec;101(6):1619-1622. doi: 10.1213/01.ANE.0000184204.81877.53.

Abstract

Clonidine is effective in treating sevoflurane-induced postanesthesia agitation in children. We conducted a study on 169 children to quantify the risk reduction of clonidine agitation in patients admitted to our day-surgery pediatric clinic. Children were randomly allocated to receive clonidine 2 mug/kg or placebo before general anesthesia with sevoflurane that was also supplemented with a regional or central block. An observer blinded to the anesthetic technique assessed recovery variables and the presence of agitation. Pain and discomfort scores were significantly decreased in the clonidine group; the incidence of agitation was reduced by 57% (P = 0.029) and the incidence of severe agitation by 67% (P = 0.064). Relative risks for developing agitation and severe agitation were 0.43 (95% confidence interval, 0.24-0.78) and 0.32 (0.09-1.17), respectively. Clonidine produces a substantial reduction in the risk of postsevoflurane agitation in children.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adrenergic alpha-Agonists / therapeutic use*
  • Anesthetics, Inhalation / adverse effects*
  • Child
  • Child, Preschool
  • Clonidine / therapeutic use*
  • Humans
  • Infant
  • Infant, Newborn
  • Methyl Ethers / adverse effects*
  • Psychomotor Agitation / drug therapy*
  • Psychomotor Agitation / etiology
  • Receptors, Adrenergic, alpha-2 / physiology
  • Sevoflurane

Substances

  • Adrenergic alpha-Agonists
  • Anesthetics, Inhalation
  • Methyl Ethers
  • Receptors, Adrenergic, alpha-2
  • Sevoflurane
  • Clonidine